Riskpilot← Back to searchSign inGet full accessSøvnløs ApS
APSActiveCVR 39725592Hollændervej 7, 1. tvActivities of holding companies · NACE 6421Est. 2018— employees
Revenue 2025
—
EBITDA margin
—
-35% vs 2024
Equity ratio
-15.1%
Financial strength
Net profit 2025
DKK -27K
-17% vs 2024
| Revenue | — | — |
| EBITDA | DKK -7K | -35% |
| Net profit | DKK -27K | -17% |
| Total assets | DKK 224K | +0% |
| Equity | DKK -34K | -383% |
| Employees | — | — |
Legal name
Søvnløs ApS
CVR number
39725592
Legal form
Anpartsselskab
NACE code
6421 · Activities of holding companies
Founded
9. juli 2018
Share capital
DKK 40.000
Employees
—
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af hele direktionen i forening eller af en direktør alene.
Company purpose
Selskabets formål er at foretage investeringer i aktiver, herunder immaterielle, og aktiviteter relaterede til forskning og udvikling rettet mod fremstilling og kommercialisering af lægemidler til diagnosticering, behandling og/eller forebyggelse af narkolepsi, narkolepsi-relaterede neurologiske sygdomme, og andre med lægemiddeludvikling relaterede aktiviteter, samt at yde konsulentydelser til selskaber, som er beskæftigede indenfor selskabets hovedformål.
Address
Hollændervej 7, 1. tv
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | -5 | -5 | -5 | -5 | — |
| Staff expenses | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -5 | -5 | -7 | -5 | -7 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 |
| EBIT | -5 | -5 | -7 | -5 | -7 |
| Net financials | -0 | -0 | -13 | -18 | -20 |
| Profit before tax | -5 | -5 | -20 | -23 | -27 |
| Tax | -0 | -0 | -0 | -0 | -0 |
| Net profit | -5 | -5 | -20 | -23 | -27 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 51 | 223 | 223 | 224 | 224 |
| Equity | 41 | 36 | 16 | -7 | -34 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 10 | 187 | 208 | 231 | 258 |
| Total debt | 10 | 187 | 208 | 231 | 258 |
EBITDA margin
-711200.0%
This company
15.8%
Market median
-4501366% vs market
20212025
Equity ratio
-15.1%
This company
38.2%
Market median
-140% vs market
20212025
Return on equity
-2678700.0%
This company
18.4%
Market median
-14558252% vs market
20212025
Net profit margin
-2678700.0%
This company
8.1%
Market median
-33070470% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
7.63×
This company
0.62×
Market median
-1131% vs market
20212025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
No data on file.
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100% | 100% | 2018 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Søvnløs ApS 
Ceremedy Holdings ApSBoard members of Søvnløs ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|